Skip to main content
Contact Us
Subscribe
E-Edition
82°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBF
Recent news which mentions RHHBF
< Previous
1
2
3
4
5
Next >
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
Health Care
IPSEY
Biotech
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
RHHVF
RHHBF
NVS
From
Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
February 03, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
Biotech
From
Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
February 02, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Health Care
Large Cap
Biotech
From
Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
Follicular Lymphoma
RHHVF
RHHBF
From
Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
January 31, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Health Care
Market News
From
Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
January 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHBF
Benzinga
From
Benzinga
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Movers
ESALY
why it's moving
From
Benzinga
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
December 20, 2021
Tickers
LCTX
RHHBF
RHHBY
RHHVF
Tags
Benzinga
Age/Related Macular Degeneration
Penny Stocks
From
Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
December 16, 2021
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
NVS
From
Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
December 15, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Market News
Phase 2 Trial
Benzinga
From
Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
December 14, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Biotech
Benzinga
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Briefs
ASH21
From
Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
December 10, 2021
Tickers
BMY
INFI
RHHBF
RHHBY
Tags
breast cancer
RHHVF
RHHBF
From
Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
December 10, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Briefs
RHHBY
From
Benzinga
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
December 07, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
RHHBY
From
Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
December 06, 2021
Tickers
IMCR
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Solid Tumor
General
From
Benzinga
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
December 03, 2021
Tickers
ABT
BDX
CI
CVS
Tags
RHHBF
RHHVF
LHDX
From
Benzinga
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
Tickers
ALPMF
ALPMY
NVS
RHHBF
Tags
Health Care
Contracts
Biotech
From
Benzinga
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
November 19, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Phase 1 Trial
Biotech
European Medicines Agency
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
Trading Ideas
NTLA
Health Care
From
Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
November 18, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
News
From
Benzinga
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill
November 17, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Contracts
Small Cap
Biotech
From
Benzinga
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
November 12, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
Briefs
From
Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
November 11, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Biotech
Health Care
REGN
From
Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
Tickers
BIIB
LLY
RHHBF
RHHBY
Tags
RHHBF
RHHVF
Briefs
From
Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
November 09, 2021
Tickers
ALXO
MRK
RHHBF
RHHBY
Tags
Health Care
Small Cap
Biotech
From
Benzinga
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
November 08, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
Biotech
From
Benzinga
Novartis To Offload Its Stake Back To Roche For $20.7B
November 04, 2021
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
Biotech
From
Benzinga
Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting
November 02, 2021
Tickers
GLTO
RHHBF
RHHBY
RHHVF
Tags
Phase 2 Trial
Market News
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.